latest update:
[TrialBase DB]

trial summary · NCT07477054

A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System

A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System - The AERO-PAS Study

Trial record from the TrialBase DB dataset, status RECRUITING, condition Ventilator Induced Diaphragm Dysfunction, sponsored by Lungpacer Medical Inc.. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07477054phase —enrollment 120start 2026-10-31

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

A single-arm, prospective, multicenter cohort study to assess the 30-day continued safety and effectiveness of the AeroPace System in patients on mechanical ventilation (MV) at least 96 hours and who have not weaned. This is a study collecting real-world data in a post-market setting.

Source record: https://clinicaltrials.gov/study/NCT07477054

Facts

registry idNCT07477054
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionVentilator Induced Diaphragm Dysfunction
sponsorLungpacer Medical Inc.
sponsor classINDUSTRY
enrollment120
start date2026-10-31
primary completion2028-08-31
completion2028-09-30
results postednot reported

Conditions

  • Ventilator Induced Diaphragm Dysfunction

Interventions

  • Lungpacer Diaphragm Pacing Therapy

Countries

  • United States

Intervention types: DEVICE

Work with this record